Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS)

The American Journal of Medicine
J A CauleyS R Cummings

Abstract

To determine if estrogen plus progestin reduces the incidence of fractures or height loss in postmenopausal women with coronary disease. We enrolled 2,763 postmenopausal women with coronary disease and with an intact uterus into the Heart Estrogen/progestin Replacement Study, a randomized double-blind, placebo-controlled secondary prevention trial of cardiovascular disease. Radiographically documented clinical fractures were a prespecified secondary endpoint. Height loss was used as a surrogate for vertebral fractures. The average age of the women was 66.7 +/- 6.7 years, and fewer than 15% of the women had osteoporosis based on their bone density. Women were randomly assigned to either 0.625 mg of conjugated equine estrogens plus 2.5 mg of medroxyprogesterone acetate in 1 tablet daily (n = 1,380) or placebo (n = 1,383). Follow-up averaged 4.1 years; 82% of those assigned to hormone treatment were taking it at the end of 1 year, and 64% at the end of the study. During 10,554 person years of follow-up, 286 women experienced a fracture: 138 in the treatment group (26.3 per 1,000 person years) and 148 in the placebo group (28.0 per 1,000 person years); relative hazard, 0.94; 95% confidence interval 0.8 to 1.2, P = 0.61). These incl...Continue Reading

References

Dec 15, 1992·Annals of Internal Medicine·D GradyS R Cummings
Jul 1, 1992·Annals of Internal Medicine·E G LufkinB L Riggs
Nov 1, 1990·American Journal of Obstetrics and Gynecology·J A CauleyD G Seeley
Jul 1, 1981·Annals of Internal Medicine·A Paganini-HillT M Mack
Jan 1, 1995·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·P MaximG M Spitalny
Feb 18, 1995·BMJ : British Medical Journal·J Windeler, S Lange

❮ Previous
Next ❯

Citations

Sep 19, 2003·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·K Lippuner
Mar 25, 2008·Therapeutics and Clinical Risk Management·Eric J MaclaughlinCynthia L Raehl
Sep 12, 2002·Pharmacotherapy·Adriane Fugh-Berman, Cynthia Pearson
Jul 23, 2005·Current Osteoporosis Reports·Rhonda A Brownbill, Jasminka Z Ilich
Sep 22, 2001·The American Journal of Medicine·A R Hoffman
May 12, 2007·Maturitas·Helena S SalminenLars-Erik Strender
Sep 26, 2007·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Kristine E EnsrudJane A Cauley
Dec 19, 2001·The American Journal of Medicine·M KleerekoperM Flather
Mar 19, 2005·Clinical calcium·Masafumi Shintani
Oct 2, 2002·Obstetrics and Gynecology Clinics of North America·Raja A Sayegh, Phillip G Stubblefield
Oct 4, 2007·Journal of the American Geriatrics Society·Jennifer Grossman, Catherine H MacLean
Aug 9, 2003·Expert Opinion on Drug Safety·Ian R Reid
May 31, 2002·Expert Opinion on Pharmacotherapy·Banu ArunBarbara Dunn
Jun 27, 2002·Expert Opinion on Pharmacotherapy·Anthony DeSantis, Alan Buchman
Nov 22, 2001·BMC Musculoskeletal Disorders·D J Torgerson, S E Bell-Syer
Jul 14, 2004·American Journal of Surgery·Edgar D Staren, Shuab Omer
Nov 17, 2004·Menopause : the Journal of the North American Menopause Society·Richard D WasnichUNKNOWN Early Postmenopausal Intervention Cohort Study Group
Oct 27, 2004·Endocrinology and Metabolism Clinics of North America·Faryal S Mirza, Karen M Prestwood
Sep 18, 2001·Journal of Women's Health & Gender-based Medicine
Feb 18, 2003·Journal of Midwifery & Women's Health·Michele R Davidson
Mar 28, 2007·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·S ForsmoA Langhammer
Jul 9, 2010·Menopause : the Journal of the North American Menopause Society·Rafael Bolaños, José Francia
Dec 20, 2005·Obstetrical & Gynecological Survey·David C McCarus
Apr 4, 2002·Drugs & Aging·Hosam K Kamel, Edmund H Duthie
Oct 9, 2004·The Journal of Clinical Endocrinology and Metabolism·Michael R McClungUNKNOWN Early Postmenopausal Intervention Cohort Study
Dec 12, 2001·The Journal of Clinical Endocrinology and Metabolism·J A CauleyUNKNOWN Study of Osteoporotic Fractures Research Group
Mar 17, 2009·The Journal of Urology·Sara L Jackson, Stephan D Fihn
Mar 16, 2012·Neurourology and Urodynamics·Karl-Dietrich SievertDiane K Newman
Oct 19, 2012·The Cochrane Database of Systematic Reviews·June D CodyAndrew Hextall
Jul 23, 2013·Neurourology and Urodynamics·Dudley RobinsonMark Vierhout
Apr 5, 2002·The Journal of Clinical Endocrinology and Metabolism·Stefano PalombaPasquale Mastrantonio
Jun 17, 2003·Clinical Obstetrics and Gynecology·Michael W Draper, William W Chin
Nov 6, 2001·The Journal of Nutrition·M J Messina, C L Loprinzi
Jun 28, 2003·The Journal of the American Academy of Orthopaedic Surgeons·William Cabot
Apr 24, 2003·The Annals of Pharmacotherapy·Samantha F EichnerErin M Timpe
Jan 25, 2002·Annals of the New York Academy of Sciences·M AnthonyB K Dunn
Jan 22, 2011·Current Opinion in Rheumatology·Jennifer M Grossman
Nov 4, 2015·Menopause : the Journal of the North American Menopause Society·Linlin ZhuWenhuan Shu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.